Royal jelly attenuates metabolic defects in a Drosophila mutant with elevated TORC1 activity

Yang Cheng1,2,3, Jiadong Cai1, Yuanyuan Fu2

  • 1College of Bioscience and Biotechnology, Yangzhou University, Yangzhou 225009, China.

Biology Open
|October 10, 2020
PubMed

Insights

Royal jelly (RJ) improves survival and metabolic health in Drosophila mutants with hyperactive TORC1 signaling. This study highlights RJ

Area of Science:

  • Cellular Metabolism
  • Molecular Biology
  • Aging Research

Background:

  • Target of rapamycin complex 1 (TORC1) regulates cell metabolism; its dysregulation is linked to diseases.
  • Nprl3 inhibits TORC1 under nutrient scarcity; nprl3 mutants show metabolic defects due to hyperactive TORC1.
  • Royal jelly (RJ) is a bee product vital for caste differentiation and has potential anti-aging properties.

Purpose of the Study:

  • To investigate the effects of Royal jelly (RJ) on metabolic modulation in nprl3-mutant Drosophila.
  • To assess RJ's impact on survival, TORC1 activity, reactive oxygen species (ROS), and energy status in nprl3 mutants.

Main Methods:

  • Utilized nprl3-mutant Drosophila melanogaster to model metabolic defects.
  • Administered Royal jelly (RJ) feeding to mutant flies.
  • Quantified survival rates, TORC1 activity, ROS levels, and energy status.
  • Characterized proteins within RJ for their role in viability.

Main Results:

  • RJ feeding significantly increased survival in nprl3 mutants.
  • RJ decreased hyperactive TORC1 signaling in the nprl3 mutant.
  • RJ ameliorated abnormal reactive oxygen species (ROS) levels and improved energy status.
  • Proteins in RJ were identified as key contributors to increased mutant viability.

Conclusions:

  • Royal jelly (RJ) effectively modulates metabolic defects associated with elevated TORC1 activity.
  • The nprl3-mutant fly serves as a valuable in vivo model for studying RJ's bioactive components.
  • RJ demonstrates potential for mitigating age-related metabolic dysfunction.

Related Concept Videos